The book presents ways to reduce the numbers of new HBV and HCV infections and the morbidity and mortality related to chronic viral hepatitis.
Hepatitis B and C cause most cases of hepatitis in the United States and the world. The two diseases account for about a million deaths a year and 78 percent of world's hepatocellular carcinoma and more than half of all fatal cirrhosis.
This issue offers the latest information regarding the transmission of hepatitis viruses in various healthcare settings.
Hepatitis C: New Treatment Helps Some, But Cure Remains Elusive
Stalking a Furtive Killer: A Review of the Federal Government's Efforts to Combat Hepatitis C : Hearing Before the Committee...
This book helps scientists, clinicians and other interested individuals understand recent clinical advances and challenges for the future.
The final section of this book covers issues related to liver transplantation in patients with chronic HCV.
WHO approved more hepatitis direct-acting antivirals (DAAs) for the treatment of infection with the hepatitis C virus (HCV) by 2020 which helped low- and middle-income countries increase the number of registered treatments, reduce prices of ...
Covers Hepatitis B and C, though the focus is on Hepatitis C.
The country has the fifth highest prevalence of hepatitis C in the world with an estimated 5.4% of adult population (150,000 persons) living with chronic HCV infection [1, 2]. Studies in various populations show that people who inject ...